한글목차

세계의 집먼지진드기 알레르기 시장은 2019년에 13억 5,410만 달러로 평가되었고 2024년까지 연평균 복합 성장률(CAGR) 9.00% 이상을 나타냈습니다.

건강 관리 지출 증가

실적 기간 동안 건강 관리 지출 증가는 집먼지진드기 알레르기 시장 성장을 지원했습니다. 위협받지 않는 질병의 진단과 관리에 자원을 할당하는 경향이 강해지고 있습니다. 보다 널리 사용되고 집먼지진드기(HDM)와 같은 유인의 더 나은 식별과 조기 치료 시작으로 이어지고 있습니다. 전문의가 도시와 반도시 양쪽으로 진출하는 것도 뒷받침하고 있습니다. 예를 들어, 2024년 1월 미국의 보건 정책 연구, 여론조사 및 저널리즘을 위한 독립 기관인 KFF의 국가 보건 지출 계정(NHEA)에 따르면 미국의 보건 지출은 2023년부터 2024년까지 5% 증가하여 4조 9,000억 달러에 달했습니다. 또한 2023년 5월, 정부 기관인 영국 통계청은 2020년과 2021년 사이에 영국의 의료비 지출이 명목상 9.4%, 실질적으로는 9.7% 증가했다는 보고서를 발표했습니다. 영국의 총 의료비는 3,672억 5,000만 달러(2,807억 파운드), 의약품비는 518억 4,000만 달러(396억 파운드), 예방 의료에 대한 지출은 2020년부터 2021년에 걸쳐 크게 증가하여 459억 3,000만 달러(351억 파운드)에 이르렀습니다.

목차

제1장 주요 요약

• 집먼지진드기 알레르기 - 시장 매력과 거시 경제 상황

제2장 목차

제3장 표 일람

제4장 그림 일람

제5장 보고서 구성

제6장 시장 특징

• 일반적인 시장 정의
• 개요
• 집먼지진드기 알레르기 시장 정의와 세분화
• 제품 유형별 시장 세분화
  • 정제
  • 비강약
  • 주사제
• 치료 유형별 시장 세분화
  • 약
  • 코 세정
  • 기타 유형
• 진단별 시장 세분화
  • 피부 단자 검사(SPT)
  • 특정 면역글로불린 E(IgE) 혈액 검사
  • 기타 진단
• 제형별 시장 세분화
  • 고체
  • 액체
• 최종 사용자별 시장 세분화
  • 병원
  • 홈케어
  • 전문 클리닉
  • 기타 최종 사용자

제7장 주요 시장 동향

• 소아 및 청소년의 알레르기 관리에서 획기적인 발전
• 알레르기 관리에서 면역 요법의 진화를 촉진하는 전략적 파트너십
• 집먼지진드기 알레르기와 천식에 대한 정밀 면역 요법의 진보
• 혁신적인 AI 탑재 알레르기 검사가 시장 역학에 혁신 창출
• 선진 면역요법정의 규제 당국의 승인

제8장 세계의 집먼지진드기 알레르기 증가 분석과 전략 분석 프레임워크

• 세계 : PESTEL 분석
  • 정치
  • 경제
  • 사회
  • 기술
  • 환경
  • 법률
• 최종 사용자(B2B) 분석
  • 병원
  • 홈케어
  • 전문 클리닉
  • 기타 최종 사용자
• 세계의 집먼지진드기 알레르기 시장 : 성장률 분석
• 시장 성장 실적(2019-2024년)
  • 시장 성장 촉진요인(2019-2024년)
  • 시장 성장 억제요인(2019-2024년)
• 시장 성장 예측(2024-2029년, 2034년)
• 성장 예측의 공헌 요인
  • 양적 성장의 기여자
  • 성장 촉진요인
  • 성장 억제요인
• 세계의 집먼지진드기 알레르기 전체 시장(TAM)

제9장 세계의 집먼지진드기 알레르기 시장 : 세분화

• 세계의 집먼지진드기 알레르기 시장 : 제품 유형별, 분석과 예측(2019-2024년, 2029년, 2034년)
• 세계의 집먼지진드기 알레르기 시장 : 치료 유형별, 분석과 예측(2019-2024년, 2029년, 2034년)
• 세계의 집먼지진드기 알레르기 시장 : 진단 유형별, 분석과 예측(2019-2024년, 2029년, 2034년)
• 세계의 집먼지진드기 알레르기 시장 : 제형별, 분석과 예측(2019-2024년, 2029년, 2034년)
• 세계의 집먼지진드기 알레르기 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2029년, 2034년)
• 세계의 집먼지진드기 알레르기 시장 : 정제 유형별, 분석과 예측(2019-2024년, 2029년, 2034년)
• 세계의 집먼지진드기 알레르기 시장 : 비강약 유형별, 분석과 예측(2019-2024년, 2029년, 2034년)
• 세계의 집먼지진드기 알레르기 시장 : 주사제 유형별, 분석과 예측(2019-2024년, 2029년, 2034년)

제10장 집먼지진드기 알레르기 시장 : 지역 및 국가별 분석

• 세계의 집먼지진드기 알레르기 시장 : 지역별, 분석과 예측(2019-2024년, 2029년, 2034년)
• 세계의 집먼지진드기 알레르기 시장 : 국가별, 분석과 예측(2019-2024년, 2029년, 2034년)

제11장 아시아태평양 시장

제12장 서유럽 시장

제13장 동유럽 시장

제14장 북미 시장

제15장 남미 시장

제16장 중동 시장

제17장 아프리카 시장

제18장 경쟁 구도와 기업 프로파일

• 기업 프로파일
• Sanofi SA
• Teva Pharmaceutical Industries Ltd.
• Johnson and Johnson
• Merck & Co. Inc.
• Bayer AG

제19장 기타 주요 기업 및 혁신 기업

• ALK - Abello A/S
• Shionogi & Co. Ltd.
• CSL Limited
• GlaxoSmithKline Plc
• Merz Pharma GmbH & Co KGaA
• Allergopharma GmbH
• Stallergenes Greer Interntional AG
• Torii Pharmaceutical Co. Ltd.
• Circassia Pharmaceuticals Plc
• Allergy Therapeutics plc.
• Trio Lifescience Private Limited
• Worg Pharmaceuticals Co. Ltd.
• Anergis SA.
• Ergomed plc
• Advagene Biopharma Co. Ltd.

제20장 경쟁 벤치마킹

제21장 경쟁 대시보드

제22장 주요 인수합병(M&A)

• Stallergenes Greer, HAL Allergy 인수

제23장 최근 동향 집먼지진드기 알레르기 시장

제24장 기회와 전략

• 세계의 집먼지진드기 알레르기 시장(2029년) : 새로운 기회를 제공하는 국가
• 세계의 집먼지진드기 알레르기 시장(2029년) : 새로운 기회를 제공하는 부문
• 세계의 집먼지진드기 알레르기 시장(2029년) : 성장 전략
  • 시장 동향에 기초한 전략
  • 경쟁 전략

제25장 집먼지진드기 알레르기 시장 : 결론과 제안

• 결론
• 권고
  • 제품
  • 장소
  • 가격
  • 프로모션
  • 사람들

제26장 부록

영문목차

House dust mite allergy, also known as dust mite allergy or dust allergy, is an allergic reaction triggered by the proteins found in the feces, body parts and secretions of dust mites. Dust mites are microscopic arthropods that thrive in indoor environments, particularly in warm, humid conditions. They are commonly found in bedding, upholstered furniture, carpets, curtains and other soft furnishings where they feed on dead skin cells shed by humans and pets.

The house dust mite allergy market consists of sales, by entities (organizations, sole traders and partnerships), of house dust mite allergy treatment products designed to either reduce exposure to allergens or to treat the symptoms and underlying immune response.

The global house dust mite allergy market was valued at $1,354.10 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 9.00%.

Rising Healthcare Expenditures

During the historic period, the rising healthcare expenditures supported the growth of the house dust mite allergy market. As healthcare spending rises, both public and private sectors increasingly allocate resources toward the diagnosis and management of chronic, non-life-threatening conditions such as allergies. With more funding, diagnostic tools such as skin prick and serum immunoglobulin E tests (IgE) are more widely used, leading to better identification of triggers like house dust mites (HDM) and earlier initiation of treatment. The growth in spending also supports the expansion of allergy and immunology specialists into both urban and semi-urban areas. For instance, in January 2024, according to national health expenditures accounts (NHEA) by KFF, a US-based independent source for health policy research, polling and journalism, health spending in the USA was increased by 5% from 2023 to 2024, reaching $4.9 trillion. Additionally, in May 2023, the UK's Office for National Statistics, a government agency, released a report stating that between 2020 and 2021, healthcare spending in the UK increased by 9.4% nominally and 9.7% practically. The total cost of healthcare in the UK in 2021 was $367.25 billion (£280.7 billion), pharmaceutical costs were $51.84 billion (£39.6 billion) and spending on preventative care increased significantly from 2020 to 2021, reaching $45.93 billion (£35.1 billion). Therefore, the rising healthcare expenditures drove the growth of the house dust mite allergy market.

Strategic Partnerships Driving The Evolution Of Immunotherapy In Allergy Care

Major companies operating in the house dust mite allergy market are adopting strategic partnerships approach to develop advanced solutions. Strategic partnerships help house dust mite allergy companies by combining resources and expertise, enhancing research and development capabilities, expanding market reach and accelerating commercialization, ultimately driving innovation and growth in the house dust mite allergy industry. For instance, in February 2025, ALK, a Denmark-based pharmaceutical company, partnered with Torii Pharmaceutical, a Japan-based pharmaceutical company, that offers house dust mite allergy tablets by granting exclusive rights to develop, market and distribute its allergy immunotherapy tablet for grass pollen allergy in Japan. This agreement builds on their existing collaboration, which already covers cedar pollen and house dust mite (HDM) allergy treatments. Torii Pharmaceutical offers sublingual immunotherapy tablets for HDM allergy under the brand MITICURE, approved for both adults and children. The expanded partnership reinforces Torii's position in the Japanese allergy treatment market and broadens its portfolio of allergen-specific therapies.

The global house dust mite allergy markets are concentrated, with large players operating in the market. The top 10 competitors in the market made up 46.17% of the total market in 2023.

House Dust Mite Allergy Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global house dust mite allergy market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for house dust mite allergy? how does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The house dust mite allergy market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider house dust mite allergy market; and compares it with other markets.

The report covers the following chapters

• Introduction And Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product type, by treatment type, by diagnosis, by dosage forms and by end users.
• Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Growth Analysis And Strategic Analysis Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
• Global Market Size And Growth- Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
• Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by product type, by treatment type, by diagnosis, by dosage forms and by end users in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
• Regional Market Size And Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
• Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
• Competitive Dashboard- Briefs on competitive dashboard of major players.
• Key Mergers And Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
• Recent Developments- Information on recent developments in the market covered in the report.
• Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations- This section includes recommendations for house dust mite allergy providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

• 1) By Product Type: Tablets; Nasal Drops; Injectable
• 2) By Treatment Type: Medication; Nasal Irrigation; Other Types
• 3) By Diagnosis: Skin Prick Test (SPT); Specific Immunoglobulin E (IgE) And Blood Test; Other Diagnostics
• 4) By Dosage Forms: Solid; Liquid
• 5) By End Users: Hospitals; Homecare; Specialty Clinics; Other End Users
• Companies Mentioned: Sanofi SA; Teva Pharmaceutical Industries Ltd.; Johnson and Johnson Services Inc.; Merck & Co. Inc.; Bayer AG
• Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; house dust mite allergy indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 House Dust Mite Allergy - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 House Dust Mite Allergy Market Definition And Segmentations
• 6.4 Market Segmentation By Product Type
  • 6.4.1 Tablets
  • 6.4.2 Nasal Drops
  • 6.4.3 Injectable
• 6.5 Market Segmentation By Treatment Type
  • 6.5.1 Medication
  • 6.5.2 Nasal Irrigation
  • 6.5.3 Other Types
• 6.6 Market Segmentation By Diagnosis
  • 6.6.1 Skin Prick Test (SPT)
  • 6.6.2 Specific Immunoglobulin E (IgE) Blood Test
  • 6.6.3 Other Diagnostics
• 6.7 Market Segmentation By Dosage Forms
  • 6.7.1 Solid
  • 6.7.2 Liquid
• 6.8 Market Segmentation By End Users
  • 6.8.1 Hospitals
  • 6.8.2 Homecare
  • 6.8.3 Specialty Clinics
  • 6.8.4 Other End Users

7 Major Market Trends

• 7.1 Breakthrough In Allergy Care For Children And Adolescents
• 7.2 Strategic Partnerships Driving The Evolution Of Immunotherapy In Allergy Care
• 7.3 Advances In Precision Immunotherapy For House Dust Mite Allergy And Asthma
• 7.4 Innovative AI-Powered Allergy Testing Revolutionizes Market Dynamics
• 7.5 Regulatory Approvals For Advanced Immunotherapy Tablets

8 Global House Dust Mite Allergy Growth Analysis And Strategic Analysis Framework

• 8.1 Global: PESTEL Analysis
  • 8.1.1 Political
  • 8.1.2 Economic
  • 8.1.3 Social
  • 8.1.4 Technological
  • 8.1.5 Environmental
  • 8.1.6 Legal
• 8.2 Analysis Of End User (B2B)
  • 8.2.1 Hospitals
  • 8.2.2 Homecare
  • 8.2.3 Specialty Clinics
  • 8.2.4 Other End Users
• 8.3 Global House Dust Mite Allergy Market Growth Rate Analysis
• 8.4 Historic Market Growth, 2019 - 2024, Value ($ Million)
  • 8.4.1 Market Drivers 2019 - 2024
  • 8.4.2 Market Restraints 2019 - 2024
• 8.5 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
• 8.6 Forecast Growth Contributors/Factors
  • 8.6.1 Quantitative Growth Contributors
  • 8.6.2 Drivers
  • 8.6.3 Restraints
• 8.7 Global House Dust Mite Allergy Total Addressable Market (TAM)

9 Global House Dust Mite Allergy Market Segmentation

• 9.1 Global House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.2 Global House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.3 Global House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.4 Global House Dust Mite Allergy Market, Segmentation By Dosage Forms, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.5 Global House Dust Mite Allergy Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.6 Global House Dust Mite Allergy Market, Sub-Segmentation Of Tablets, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.7 Global House Dust Mite Allergy Market, Sub-Segmentation Of Nasal Drops, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 9.8 Global House Dust Mite Allergy Market, Sub-Segmentation Of Injectable, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

10 House Dust Mite Allergy Market, Regional and Country Analysis

• 10.1 Global House Dust Mite Allergy Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 10.2 Global House Dust Mite Allergy Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

• 11.1 Summary
• 11.2 Market Overview
  • 11.2.1 Region Information
  • 11.2.2 Market Information
  • 11.2.3 Background Information
  • 11.2.4 Government Initiatives
  • 11.2.5 Regulations
  • 11.2.6 Regulatory Bodies
  • 11.2.7 Major Associations
  • 11.2.8 Taxes Levied
  • 11.2.9 Corporate Tax Structure
  • 11.2.10 Investments
  • 11.2.11 Major Companies
• 11.3 Asia-Pacific House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.4 Asia-Pacific House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.5 Asia-Pacific House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.6 Asia-Pacific House Dust Mite Allergy Market: Country Analysis
• 11.7 China Market
• 11.8 Summary
• 11.9 Market Overview
  • 11.9.1 Country Information
  • 11.9.2 Market Information
  • 11.9.3 Background Information
  • 11.9.4 Government Initiatives
  • 11.9.5 Regulations
  • 11.9.6 Regulatory Bodies
  • 11.9.7 Major Associations
  • 11.9.8 Taxes Levied
  • 11.9.9 Corporate Tax Structure
  • 11.9.10 Investments
  • 11.9.11 Major Companies
• 11.10 China House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.11 China House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.12 China House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.13 India Market
• 11.14 India House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.15 India House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.16 India House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.17 Japan Market
• 11.18 Summary
• 11.19 Market Overview
  • 11.19.1 Country Information
  • 11.19.2 Market Information
  • 11.19.3 Background Information
  • 11.19.4 Government Initiatives
  • 11.19.5 Regulations
  • 11.19.6 Regulatory Bodies
  • 11.19.7 Major Associations
  • 11.19.8 Taxes Levied
  • 11.19.9 Corporate Tax Structure
  • 11.19.10 Investments
  • 11.19.11 Major Companies
• 11.20 Japan House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.21 Japan House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.22 Japan House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.23 South Korea Market
• 11.24 Summary
• 11.25 Market Overview
  • 11.25.1 Country Information
  • 11.25.2 Market Information
  • 11.25.3 Background Information
  • 11.25.4 Regulations
  • 11.25.5 Regulatory Bodies
  • 11.25.6 Major Associations
  • 11.25.7 Taxes Levied
  • 11.25.8 Corporate Tax Structure
  • 11.25.9 Major Companies
• 11.26 South Korea House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.27 South Korea House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.28 South Korea House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.29 Australia Market
• 11.30 Australia House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.31 Australia House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.32 Australia House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.33 Indonesia Market
• 11.34 Indonesia House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.35 Indonesia House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.36 Indonesia House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

• 12.1 Summary
• 12.2 Market Overview
  • 12.2.1 Region Information
  • 12.2.2 Market Information
  • 12.2.3 Background Information
  • 12.2.4 Government Initiatives
  • 12.2.5 Regulations
  • 12.2.6 Regulatory Bodies
  • 12.2.7 Major Associations
  • 12.2.8 Taxes Levied
  • 12.2.9 Corporate tax structure
  • 12.2.10 Investments
  • 12.2.11 Major Companies
• 12.3 Western Europe House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.4 Western Europe House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.5 Western Europe House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.6 Western Europe House Dust Mite Allergy Market: Country Analysis
• 12.7 UK Market
• 12.8 UK House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.9 UK House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.10 UK House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.11 Germany Market
• 12.12 Germany House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.13 Germany House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.14 Germany House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.15 France Market
• 12.16 France House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.17 France House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.18 France House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.19 Italy Market
• 12.20 Italy House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.21 Italy House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.22 Italy House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.23 Spain Market
• 12.24 Spain House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.25 Spain House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.26 Spain House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

• 13.1 Summary
• 13.2 Market Overview
  • 13.2.1 Region Information
  • 13.2.2 Market Information
  • 13.2.3 Background Information
  • 13.2.4 Government Initiatives
  • 13.2.5 Regulations
  • 13.2.6 Regulatory Bodies
  • 13.2.7 Major Associations
  • 13.2.8 Taxes Levied
  • 13.2.9 Corporate Tax Structure
  • 13.2.10 Major companies
• 13.3 Eastern Europe House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.4 Eastern Europe House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.5 Eastern Europe House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.6 Russia Market
• 13.7 Russia House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.8 Russia House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.9 Russia House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

• 14.1 Summary
• 14.2 Market Overview
  • 14.2.1 Region Information
  • 14.2.2 Market Information
  • 14.2.3 Background Information
  • 14.2.4 Government Initiatives
  • 14.2.5 Regulations
  • 14.2.6 Regulatory Bodies
  • 14.2.7 Major Associations
  • 14.2.8 Taxes Levied
  • 14.2.9 Corporate Tax Structure
  • 14.2.10 Investments
  • 14.2.11 Major Companies
• 14.3 North America House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.4 North America House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.5 North America House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.6 North America House Dust Mite Allergy Market: Country Analysis
• 14.7 USA Market
• 14.8 Summary
• 14.9 Market Overview
  • 14.9.1 Country Information
  • 14.9.2 Market Information
  • 14.9.3 Background Information
  • 14.9.4 Government Initiatives
  • 14.9.5 Regulations
  • 14.9.6 Regulatory Bodies
  • 14.9.7 Major Associations
  • 14.9.8 Taxes Levied
  • 14.9.9 Corporate Tax Structure
  • 14.9.10 Investments
  • 14.9.11 Major Companies
• 14.10 USA House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.11 USA House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.12 USA House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.13 Canada Market
• 14.14 Summary
• 14.15 Market Overview
  • 14.15.1 Country Information
  • 14.15.2 Market Information
  • 14.15.3 Background Information
  • 14.15.4 Government Initiatives
  • 14.15.5 Regulations
  • 14.15.6 Regulatory Bodies
  • 14.15.7 Major Associations
  • 14.15.8 Taxes Levied
  • 14.15.9 Corporate Tax Structure
  • 14.15.10 Major Companies
• 14.16 Canada House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.17 Canada House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.18 Canada House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

• 15.1 Summary
• 15.2 Market Overview
  • 15.2.1 Region Information
  • 15.2.2 Market Information
  • 15.2.3 Background Information
  • 15.2.4 Government Initiatives
  • 15.2.5 Regulations
  • 15.2.6 Regulatory Bodies
  • 15.2.7 Major Associations
  • 15.2.8 Taxes Levied
  • 15.2.9 Corporate Tax Structure
  • 15.2.10 Major Companies
• 15.3 South America House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.4 South America House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.5 South America House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.6 Brazil Market
• 15.7 Brazil House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.8 Brazil House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.9 Brazil House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

• 16.1 Summary
• 16.2 Market Overview
  • 16.2.1 Region Information
  • 16.2.2 Market Information
  • 16.2.3 Background Information
  • 16.2.4 Government Initiatives
  • 16.2.5 Regulations
  • 16.2.6 Regulatory Bodies
  • 16.2.7 Major Associations
  • 16.2.8 Taxes Levied
  • 16.2.9 Corporate Tax Structure
  • 16.2.10 Major Companies
• 16.3 Middle East House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 16.4 Middle East House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 16.5 Middle East House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

• 17.1 Summary
• 17.2 Market Overview
  • 17.2.1 Region Information
  • 17.2.2 Market Information
  • 17.2.3 Background Information
  • 17.2.4 Government Initiatives
  • 17.2.5 Regulations
  • 17.2.6 Regulatory Bodies
  • 17.2.7 Major Associations
  • 17.2.8 Taxes Levied
  • 17.2.9 Corporate Tax Structure
  • 17.2.10 Major Companies
• 17.3 Africa House Dust Mite Allergy Market, Segmentation By Product Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 17.4 Africa House Dust Mite Allergy Market, Segmentation By Treatment Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 17.5 Africa House Dust Mite Allergy Market, Segmentation By Diagnosis, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

• 18.1 Company Profiles
• 18.2 Sanofi SA
  • 18.2.1 Company Overview
  • 18.2.2 Products And Services
  • 18.2.3 Financial Overview
• 18.3 Teva Pharmaceutical Industries Ltd.
  • 18.3.1 Company Overview
  • 18.3.2 Products And Services
  • 18.3.3 Financial Overview
• 18.4 Johnson and Johnson
  • 18.4.1 Company Overview
  • 18.4.2 Products And Services
  • 18.4.3 Financial Overview
• 18.5 Merck & Co. Inc.
  • 18.5.1 Company Overview
  • 18.5.2 Products And Services
  • 18.5.3 Business Strategy
  • 18.5.4 Financial Overview
• 18.6 Bayer AG
  • 18.6.1 Company Overview
  • 18.6.2 Products And Services
  • 18.6.3 Financial Overview

19 Other Major And Innovative Companies

• 19.1 ALK-Abello A/S
  • 19.1.1 Company Overview
  • 19.1.2 Products And Services
• 19.2 Shionogi & Co. Ltd.
  • 19.2.1 Company Overview
  • 19.2.2 Products And Services
• 19.3 CSL Limited
  • 19.3.1 Company Overview
  • 19.3.2 Products And Services
• 19.4 GlaxoSmithKline Plc
  • 19.4.1 Company Overview
  • 19.4.2 Products And Services
• 19.5 Merz Pharma GmbH & Co KGaA
  • 19.5.1 Company Overview
  • 19.5.2 Products And Services
• 19.6 Allergopharma GmbH
  • 19.6.1 Company Overview
  • 19.6.2 Products And Services
• 19.7 Stallergenes Greer Interntional AG
  • 19.7.1 Company Overview
  • 19.7.2 Products And Services
• 19.8 Torii Pharmaceutical Co. Ltd.
  • 19.8.1 Company Overview
  • 19.8.2 Products And Services
• 19.9 Circassia Pharmaceuticals Plc
  • 19.9.1 Company Overview
  • 19.9.2 Products And Services
• 19.10 Allergy Therapeutics plc.
  • 19.10.1 Company Overview
  • 19.10.2 Products And Services
• 19.11 Trio Lifescience Private Limited
  • 19.11.1 Company Overview
  • 19.11.2 Products And Services
• 19.12 Worg Pharmaceuticals Co. Ltd.
  • 19.12.1 Company Overview
  • 19.12.2 Products And Services
• 19.13 Anergis SA.
  • 19.13.1 Company Overview
  • 19.13.2 Products And Services
• 19.14 Ergomed plc
  • 19.14.1 Company Overview
  • 19.14.2 Products And Services
• 19.15 Advagene Biopharma Co. Ltd.
  • 19.15.1 Company Overview
  • 19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

• 22.1 Stallergenes Greer Acquired HAL Allergy

23 Recent Developments In The House Dust Mite Allergy Market

• 23.1 Revolutionary Treatment For House Dust Mite Allergies Secures NHS Approval

24 Opportunities And Strategies

• 24.1 Global House Dust Mite Allergy Market In 2029 - Countries Offering Most New Opportunities
• 24.2 Global House Dust Mite Allergy Market In 2029 - Segments Offering Most New Opportunities
• 24.3 Global House Dust Mite Allergy Market In 2029 - Growth Strategies
  • 24.3.1 Market Trend Based Strategies
  • 24.3.2 Competitor Strategies

25 House Dust Mite Allergy Market, Conclusions And Recommendations

• 25.1 Conclusions
• 25.2 Recommendations
  • 25.2.1 Product
  • 25.2.2 Place
  • 25.2.3 Price
  • 25.2.4 Promotion
  • 25.2.5 People

26 Appendix

• 26.1 Geographies Covered
• 26.2 Market Data Sources
• 26.3 Research Methodology
• 26.4 Currencies
• 26.5 The Business Research Company
• 26.6 Copyright and Disclaimer